The protein aggregation inhibitor YAT2150 has potent antimalarial activity in Plasmodium falciparum in vitro cultures

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1741-7007

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: The protein aggregation inhibitor YAT2150 has potent antimalarial activity in Plasmodium falciparum in vitro cultures ; volume:20 ; number:1 ; day:22 ; month:10 ; year:2022 ; pages:1-27 ; date:12.2022
BMC biology ; 20, Heft 1 (22.10.2022), 1-27, 12.2022

Creator: Bouzón-Arnáiz, Inés
Avalos-Padilla, Yunuen
Biosca, Arnau
Caño-Prades, Omar
Román-Álamo, Lucía
Valle, Javier
Andreu, David
Moita, Diana
Prudêncio, Miguel
Arce, Elsa M.
Muñoz-Torrero, Diego
Fernàndez-Busquets, Xavier

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12915-022-01374-4

URN: urn:nbn:de:101:1-2022112421340737094966

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 2025-08-15T07:22:49+0200

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bouzón-Arnáiz, Inés
Avalos-Padilla, Yunuen
Biosca, Arnau
Caño-Prades, Omar
Román-Álamo, Lucía
Valle, Javier
Andreu, David
Moita, Diana
Prudêncio, Miguel
Arce, Elsa M.
Muñoz-Torrero, Diego
Fernàndez-Busquets, Xavier
SpringerLink (Online service)

Other Objects (12)

Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity

Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones

Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum

Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?

Evaluating antimalarial efficacy by tracking glycolysis in Plasmodium falciparum using NMR spectroscopy

Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis

Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum

Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance

Mechanisms of microbial co-aggregation in mixed anaerobic cultures

Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4

Optimized and convergent synthesis of potent anti-malarial aminoquinoline compounds: easy access to analogs

2-tert-butyl-primaquine exhibit potent blood schizontocidal antimalarial activity via inhibition of heme crystallization

Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity

Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones

Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum

Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?

Evaluating antimalarial efficacy by tracking glycolysis in Plasmodium falciparum using NMR spectroscopy

Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis

Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum

Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance

Mechanisms of microbial co-aggregation in mixed anaerobic cultures

Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4

Optimized and convergent synthesis of potent anti-malarial aminoquinoline compounds: easy access to analogs

2-tert-butyl-primaquine exhibit potent blood schizontocidal antimalarial activity via inhibition of heme crystallization

Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity

Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones

Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum

Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?

Evaluating antimalarial efficacy by tracking glycolysis in Plasmodium falciparum using NMR spectroscopy

Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis

Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum

Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance

Mechanisms of microbial co-aggregation in mixed anaerobic cultures

Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4

Optimized and convergent synthesis of potent anti-malarial aminoquinoline compounds: easy access to analogs

2-tert-butyl-primaquine exhibit potent blood schizontocidal antimalarial activity via inhibition of heme crystallization

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The protein aggregation inhibitor YAT2150 has potent antimalarial activity in Plasmodium falciparum in vitro cultures

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity

Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones

Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum

Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?

Evaluating antimalarial efficacy by tracking glycolysis in Plasmodium falciparum using NMR spectroscopy

Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis

Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum

Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance

Mechanisms of microbial co-aggregation in mixed anaerobic cultures

Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4

Optimized and convergent synthesis of potent anti-malarial aminoquinoline compounds: easy access to analogs

2-tert-butyl-primaquine exhibit potent blood schizontocidal antimalarial activity via inhibition of heme crystallization

Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity

Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones

Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum

Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?

Evaluating antimalarial efficacy by tracking glycolysis in Plasmodium falciparum using NMR spectroscopy

Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis

Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum

Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance

Mechanisms of microbial co-aggregation in mixed anaerobic cultures

Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4

Optimized and convergent synthesis of potent anti-malarial aminoquinoline compounds: easy access to analogs

2-tert-butyl-primaquine exhibit potent blood schizontocidal antimalarial activity via inhibition of heme crystallization

Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity

Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones

Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum

Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?

Evaluating antimalarial efficacy by tracking glycolysis in Plasmodium falciparum using NMR spectroscopy

Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis

Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum

Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance

Mechanisms of microbial co-aggregation in mixed anaerobic cultures

Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4

Optimized and convergent synthesis of potent anti-malarial aminoquinoline compounds: easy access to analogs

2-tert-butyl-primaquine exhibit potent blood schizontocidal antimalarial activity via inhibition of heme crystallization

Related objects

Reset password